Takara Bio Inc
TSE:4974

Watchlist Manager
Takara Bio Inc Logo
Takara Bio Inc
TSE:4974
Watchlist
Price: 802 JPY 1.78% Market Closed
Market Cap: ¥96.6B

Balance Sheet

Balance Sheet Decomposition
Takara Bio Inc

Balance Sheet
Takara Bio Inc

Rotate your device to view
Balance Sheet
Currency: JPY
Mar-2003 Mar-2004 Mar-2005 Mar-2006 Mar-2007 Mar-2008 Mar-2009 Mar-2010 Mar-2011 Mar-2012 Mar-2013 Mar-2014 Mar-2015 Mar-2016 Mar-2017 Mar-2018 Mar-2019 Mar-2020 Mar-2021 Mar-2022 Mar-2023 Mar-2024 Mar-2025
Assets
Cash & Cash Equivalents
3 091
6 464
13 534
7 065
5 166
8 653
8 932
13 763
17 429
17 880
18 267
21 302
20 584
19 384
28 078
17 537
17 033
18 266
25 993
23 633
51 847
35 416
29 549
Cash Equivalents
3 091
6 464
13 534
7 065
5 166
8 653
8 932
13 763
17 429
17 880
18 267
21 302
20 584
19 384
28 078
17 537
17 033
18 266
25 993
23 633
51 847
35 416
29 549
Short-Term Investments
26
27
0
2 539
5 678
7 310
7 555
4 647
1 599
2 527
2 518
8 631
3 299
9 721
2 000
2 000
2 000
2 000
0
0
0
0
0
Total Receivables
4 832
4 605
4 342
5 472
5 697
5 551
4 768
4 637
4 705
5 519
5 951
6 234
6 691
6 789
7 425
7 989
8 563
9 046
12 585
17 804
12 448
11 285
14 017
Accounts Receivables
4 832
4 605
4 342
5 472
5 697
5 551
4 768
4 637
4 705
5 519
5 951
6 234
6 691
6 789
7 425
7 989
8 563
9 046
12 585
17 338
12 204
11 252
13 997
Other Receivables
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
466
244
33
20
Inventory
2 622
2 687
2 408
3 943
3 493
3 175
3 286
3 075
2 881
3 093
3 466
4 420
4 637
5 099
5 461
6 010
6 735
7 593
9 183
24 065
11 087
11 850
12 439
Other Current Assets
1 809
545
559
1 020
3 664
724
1 132
1 106
805
838
936
1 230
1 236
1 165
1 000
980
944
1 482
1 354
2 639
2 187
4 208
1 674
Total Current Assets
12 380
14 328
20 843
20 039
23 698
25 413
25 673
27 228
27 419
29 857
31 138
41 817
36 447
42 158
43 964
34 516
35 275
38 387
49 115
68 141
77 569
62 759
57 679
PP&E Net
12 562
12 294
12 884
13 791
12 416
12 355
11 752
11 457
10 888
10 542
12 196
16 960
20 532
20 534
19 577
18 534
21 404
24 213
29 766
36 395
40 956
49 075
56 954
PP&E Gross
12 562
12 294
12 884
13 791
12 416
12 355
11 752
11 457
10 888
10 542
12 196
16 960
20 532
20 534
19 577
18 534
21 404
24 213
29 766
36 395
40 956
49 075
56 954
Accumulated Depreciation
8 132
9 064
10 126
12 817
12 740
12 487
12 837
12 895
12 405
11 329
11 966
13 036
13 955
13 598
13 517
15 600
13 783
14 325
14 329
15 886
18 600
22 129
25 347
Intangible Assets
605
612
873
1 718
1 653
1 626
926
825
911
837
804
1 110
1 157
1 054
1 088
5 904
5 030
4 349
3 224
2 850
2 373
1 539
1 455
Goodwill
77
0
0
2 995
2 879
2 805
1 950
1 830
1 501
1 313
1 331
1 477
1 840
1 641
1 213
8 259
7 598
7 006
6 149
6 309
6 674
6 488
6 516
Long-Term Investments
1 290
2 003
1 207
1 758
1 586
404
164
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Other Long-Term Assets
3 140
2 404
1 616
4 135
3 302
2 678
2 644
2 304
1 866
1 483
1 180
1 136
1 451
1 204
1 301
1 457
1 733
1 054
1 496
2 017
1 630
1 391
2 730
Other Assets
77
0
0
2 995
2 879
2 805
1 950
1 830
1 501
1 313
1 331
1 477
1 840
1 641
1 213
8 259
7 598
7 006
6 149
6 309
6 674
6 488
6 516
Total Assets
30 054
N/A
31 641
+5%
37 423
+18%
44 436
+19%
45 534
+2%
45 281
-1%
43 109
-5%
43 644
+1%
42 585
-2%
44 032
+3%
46 649
+6%
62 500
+34%
66 425
+6%
66 591
+0%
67 143
+1%
68 670
+2%
71 040
+3%
75 009
+6%
89 750
+20%
115 712
+29%
129 202
+12%
121 252
-6%
125 334
+3%
Liabilities
Accounts Payable
1 033
912
752
1 194
1 574
1 221
1 432
1 335
1 168
1 662
1 605
1 551
1 939
1 690
1 944
1 875
1 536
1 027
2 077
1 959
2 323
1 543
1 652
Accrued Liabilities
244
243
265
253
252
240
259
296
177
174
179
197
191
196
425
333
593
557
739
923
1 065
962
1 003
Short-Term Debt
129
247
57
44
44
0
0
0
0
0
18
88
9
16
0
0
0
0
0
0
0
0
0
Current Portion of Long-Term Debt
0
0
0
0
0
44
45
45
45
58
65
49
0
48
47
0
0
134
138
137
151
180
193
Other Current Liabilities
3 128
1 420
1 383
2 301
2 495
2 132
2 051
2 177
1 714
1 940
2 110
2 487
3 251
3 480
3 609
3 537
3 888
4 530
10 237
14 361
10 836
4 483
4 283
Total Current Liabilities
4 534
2 822
2 457
3 792
4 365
3 637
3 787
3 853
3 104
3 834
3 977
4 372
5 439
5 430
6 025
5 745
6 017
6 248
13 191
17 380
14 375
7 168
7 131
Long-Term Debt
1 618
1 453
1 395
590
546
501
455
410
364
335
273
227
179
130
82
0
0
986
1 003
910
821
788
908
Deferred Income Tax
448
408
371
1 431
882
524
356
212
44
90
120
183
0
196
210
0
0
0
0
198
179
0
0
Minority Interest
969
423
362
245
165
110
0
0
11
51
50
58
101
102
100
106
85
95
120
191
235
279
348
Other Liabilities
872
818
895
1 074
1 127
1 513
1 365
1 371
1 455
1 359
814
591
726
725
841
966
928
1 184
1 254
1 160
1 373
1 512
1 446
Total Liabilities
8 441
N/A
5 924
-30%
5 480
-7%
7 132
+30%
7 085
-1%
6 285
-11%
5 963
-5%
5 846
-2%
4 978
-15%
5 669
+14%
5 234
-8%
5 431
+4%
6 884
+27%
6 583
-4%
7 258
+10%
6 817
-6%
7 030
+3%
8 513
+21%
15 568
+83%
19 839
+27%
16 983
-14%
9 747
-43%
9 833
+1%
Equity
Common Stock
1 000
3 055
5 993
8 739
8 976
9 022
9 040
9 053
9 068
9 069
9 233
14 965
14 965
14 965
14 965
14 965
14 965
14 965
14 965
14 965
14 965
14 965
14 965
Retained Earnings
1 094
936
356
583
1 358
2 035
2 364
2 956
3 561
4 584
5 934
7 280
8 142
9 295
10 432
12 285
15 401
18 501
27 085
45 009
57 047
53 471
52 465
Additional Paid In Capital
21 693
21 775
26 373
28 289
26 904
26 949
26 967
26 980
26 995
26 996
27 160
32 893
32 893
32 893
32 893
32 893
32 893
32 893
32 893
32 893
32 893
32 893
32 893
Unrealized Security Profit/Loss
13
39
95
0
0
289
109
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Treasury Stock
0
0
0
3
3
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Other Equity
30
88
25
864
1 211
700
1 332
1 191
2 017
2 287
912
1 931
3 541
2 855
1 595
1 710
751
137
761
3 006
7 314
10 176
15 178
Total Equity
21 616
N/A
25 717
+19%
31 940
+24%
37 306
+17%
38 446
+3%
38 995
+1%
37 148
-5%
37 798
+2%
37 607
-1%
38 362
+2%
41 415
+8%
57 069
+38%
59 541
+4%
60 008
+1%
59 885
0%
61 853
+3%
64 010
+3%
66 496
+4%
74 182
+12%
95 873
+29%
112 219
+17%
111 505
-1%
115 501
+4%
Total Liabilities & Equity
30 057
N/A
31 641
+5%
37 420
+18%
44 438
+19%
45 531
+2%
45 280
-1%
43 111
-5%
43 644
+1%
42 585
-2%
44 031
+3%
46 649
+6%
62 500
+34%
66 425
+6%
66 591
+0%
67 143
+1%
68 670
+2%
71 040
+3%
75 009
+6%
89 750
+20%
115 712
+29%
129 202
+12%
121 252
-6%
125 334
+3%
Shares Outstanding
Common Shares Outstanding
105
105
105
112
113
113
113
113
113
113
114
120
120
120
120
120
120
120
120
120
120
120
120